Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2015; 04(04): 188
DOI: 10.4103/2278-330X.175959
None

Palliative low dose fortnightly methotrexate in oral cancer

Sim Sai Tin
Shantou Medical Center, Shantou
,
Viroj Wiwanitkit
Hainan Medical University, Haikou
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
31 December 2020

© 2015. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Chakraborty S, Geetha M, Sujith KM, Biji MS, Sateeshan B. Palliative low dose fortnightly methotrexate in oral cancers: Experience at a rural cancer centre from India. South Asian J Cancer 2014;3:166-70.
  • 2 Jones WG, Fosså SD, Verbaeys AC, Droz JP, Klijn JG, Boven E, et al. Low-dose fortnightly methotrexate in advanced prostate cancer. The EORTC Genito-Urinary Tract Cancer Cooperative Group. Eur J Cancer 1990;26:646.
  • 3 Shiver MB, Hall LA, Conner KB, Brown GE, Cheung WL, Wirges ML. Cutaneous erosions: A herald for impending pancytopenia in methotrexate toxicity. Dermatol Online J 2014;20.
  • 4 Shea B, Swinden MV, Ghogomu ET, Ortiz Z, Katchamart W, Rader T, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. J Rheumatol 2014;41:1049-60.